EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Paragon Care's Enterprise Value is A$624 Mil.
Paragon Care's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-25 Mil. Therefore, Paragon Care's EV-to-FCF for today is -25.39.
The historical rank and industry rank for Paragon Care's EV-to-FCF or its related term are showing as below:
ASX:PGC'
s EV-to-FCF Range Over the Past 10 Years
Min: -122.14 Med: 10.68 Max: 231.37
Current: -25.39
During the past 13 years, the highest EV-to-FCF of Paragon Care was 231.37. The lowest was -122.14. And the median was 10.68.
ASX:PGC's EV-to-FCF is ranked worse than 100% of 74
companies
in the Medical Distribution industry
Industry Median: 16.95
vs ASX:PGC: -25.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Paragon Care's PE Ratio (TTM) for today is calculated as:
Paragon Care's share price for today is A$0.155.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paragon Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Paragon Care EV-to-FCF Related Terms
Paragon Care EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Paragon Care's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Paragon Care's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon Care EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Paragon Care's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Paragon Care's EV-to-FCF falls into.
Paragon Care's current Enterprise Value is A$624 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paragon Care's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon Care (ASX:PGC) has a EV-to-FCF of -25.39 as of Jul. 05, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Paragon Care and its competitors. According to the industry distribution chart, Paragon Care ranks #999999 out of 74 companies in the Medical Distribution industry.
Is Paragon Care's EV-to-FCF too high?
Paragon Care's current EV-to-FCF is -25.39. Based on the distribution chart, Paragon Care ranks #999999 out of 74 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Paragon Care has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Paragon Care ranks #999999 out of 74 companies for EV-to-FCF. This places Paragon Care in the lower half of its industry. The industry median EV-to-FCF is 16.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.95, based on 74 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Paragon Care and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paragon Care's current EV-to-FCF is -25.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (ASX:PGC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.40, compared to a current price of A$0.16 — trading 61.3% below its estimated fair value. The current EV-to-FCF is -25.39. Paragon Care's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Paragon Care (ASX:PGC), the current EV-to-FCF is -25.39 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paragon Care (ASX:PGC) Overvalued in 2026?
Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued.
The current stock price of A$0.16 is trading 61.3% below its estimated GF Value™ of A$0.40.
GuruFocus considers Paragon Care to be Possible Value Trap.
Key valuation signals for ASX:PGC:
EV-to-FCF: -25.39
GF Value™: A$0.40 vs. price of A$0.16 (61.3% below fair value)
No single metric tells the full story. See the ASX:PGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
56GF Score
Get the complete analysis for ASX:PGC
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PGC has been successfully added to your 
